Research Group in Gene-Environment Interactions and Health, Institute of Biomedicine (IBIOMED), University of León, León, Spain.
Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
PLoS One. 2021 Dec 3;16(12):e0260769. doi: 10.1371/journal.pone.0260769. eCollection 2021.
The Spanish health system is made up of seventeen regional health systems. Through the official reporting systems, some inconsistencies and differences in case fatality rates between Autonomous Communities (CC.AA.) have been observed. Therefore the objective of this paper is to compare COVID-19 case fatality rates across the Spanish CC.AA.
Observational descriptive study. The COVID-19 case fatality rate (CFR) was estimated according to the official records (CFR-PCR+), the daily mortality monitory system (MoMo) record (CFR-Mo), and the seroprevalence study ENE-COVID-19 (Estudio Nacional de sero Epidemiologia Covid-19) according to sex, age group and CC.AA. between March and June 2020. The main objective is to detect whether there are any differences in CFR between Spanish Regions using two different register systems, i. e., the official register of the Ministry of Health and the MoMo.
Overall, the CFR-Mo was higher than the CFR-PCR+, 1.59% vs 0.98%. The differences in case fatality rate between both methods were significantly higher in Castilla La Mancha, Castilla y León, Cataluña, and Madrid. The difference between both methods was higher in persons over 74 years of age (CFR-PCR+ 7.5% vs 13.0% for the CFR-Mo) but without statistical significance. There was no correlation of the estimated prevalence of infection with CFR-PCR+, but there was with CFR-Mo (R2 = 0.33). Andalucía presented a SCFR below 1 with both methods, and Asturias had a SCFR higher than 1. Cataluña and Castilla La Mancha presented a SCFR greater than 1 in any scenario of SARS-CoV-2 infection calculated with SCFR-Mo.
The PCR+ case fatality rate underestimates the case fatality rate of the SARS-CoV- 2 virus pandemic. It is therefore preferable to consider the MoMo case fatality rate. Significant differences have been observed in the information and registration systems and in the severity of the pandemic between the Spanish CC.AA. Although the infection prevalence correlates with case fatality rate, other factors such as age, comorbidities, and the policies adopted to address the pandemic can explain the differences observed between CC.AA.
西班牙的卫生系统由 17 个地区卫生系统组成。通过官方报告系统,观察到各自治区(CC.AA.)之间病死率存在一些不一致和差异。因此,本文的目的是比较西班牙各自治区的 COVID-19 病死率。
观察性描述性研究。根据官方记录(PCR+ 病死率)、每日死亡率监测系统(MoMo)记录(Mo 病死率)和 ENE-COVID-19 血清流行病学研究(Estudio Nacional de sero Epidemiologia Covid-19)估算 COVID-19 病死率(CFR),按性别、年龄组和 CC.AA.进行分组。2020 年 3 月至 6 月。主要目的是使用两种不同的登记系统(即卫生部的官方登记系统和 MoMo)检测西班牙各地区之间的 CFR 是否存在差异。
总体而言,Mo 病死率高于 PCR+病死率,分别为 1.59%和 0.98%。Mo 法和 PCR+法的病死率差异在卡斯蒂利亚拉曼查、卡斯蒂利亚-莱昂、加泰罗尼亚和马德里地区差异更为显著。在 74 岁以上人群中,Mo 法和 PCR+法之间的病死率差异更高(Mo 法为 7.5%,PCR+法为 13.0%),但无统计学意义。Mo 法估计的感染流行率与 CFR-PCR+无相关性,但与 MoMo 法(R2=0.33)有相关性。在任何 SARS-CoV-2 感染计算的 Mo 病死率情景下,安达卢西亚和阿斯图里亚斯的校正病死率均低于 1,加泰罗尼亚和卡斯蒂利亚-拉曼查的校正病死率均高于 1。
PCR+病死率低估了 SARS-CoV-2 病毒大流行的病死率。因此,最好考虑使用 MoMo 病死率。在信息和登记系统以及大流行的严重程度方面,西班牙各自治区之间存在显著差异。尽管感染流行率与病死率相关,但年龄、合并症和应对大流行所采取的政策等其他因素可以解释各自治区之间观察到的差异。